{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:33:32Z","timestamp":1792701212967,"version":"4.5.0"},"reference-count":60,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1667,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1365-2516.2010.02460.x","type":"journal-article","created":{"date-parts":[[2011,2,7]],"date-time":"2011-02-07T09:58:18Z","timestamp":1297072698000},"page":"579-589","source":"Crossref","is-referenced-by-count":47,"title":["Surgical Experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX"],"prefix":"10.1111","volume":"17","author":[{"given":"L. A.","family":"VALENTINO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. L.","family":"COOPER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"GOLDSTEIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,7]]},"reference":[{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood-2003-03-0941","article-title":"Cost of care and quality of life in hemophilia complicated by inhibitors: the COCIS Study Group","volume":"102","author":"Gringeri","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2516.2006.01204.x","article-title":"Quality of life is associated to the orthopaedic status in haemophiliac patients with inhibitors","volume":"12","author":"Scalone","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2516.2007.01518.x","article-title":"European study on orthopaedic status of haemophilia patients with inhibitors","volume":"13","author":"Morfini","year":"2007","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1053\/j.seminhematol.2008.03.009","article-title":"Controversies and challenges in elective orthopedic surgery in patients with hemophilia and inhibitors","volume":"45","author":"Jim\u00e9nez-Yuste","year":"2008","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0038-1646159","article-title":"Treatment of patients with factor VIII and IX inhibitors","volume":"70","author":"Nilsson","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB6|cit6","first-page":"20","article-title":"Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects","volume":"31","author":"Hay","year":"1994","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB7|cit7","first-page":"49","article-title":"Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors--benefits and limitations","volume":"31","author":"Lusher","year":"1994","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0037-1615357","article-title":"Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery 890","volume":"80","author":"Shapiro","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1160\/TH07-03-0198","article-title":"Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial","volume":"98","author":"Pruthi","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00001721-200104000-00009","article-title":"Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery","volume":"12","author":"Biron-Andreani","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02981987","article-title":"Successful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor","volume":"75","author":"Carr","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1365-2516.2001.0537a.x","article-title":"A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors","volume":"7","author":"Chuansumrit","year":"2001","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2710.2002.00394.x","article-title":"Experience with use of recombinant activated factor VII","volume":"27","author":"Divanon","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2516.2001.00501.x","article-title":"Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven((R))): a new case report and review of the literature","volume":"7","author":"Faradji","year":"2001","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1111\/j.1365-2516.2010.02460.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2516.2005.01155.x","article-title":"Case studies: orthopaedic surgery in adult patients with haemophilia A with inhibitors","volume":"11","author":"Goddard","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB16|cit16","first-page":"1","article-title":"Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody","volume":"21","author":"Gringeri","year":"1991","journal-title":"Haemostasis"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(88)90259-0","article-title":"Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy","volume":"2","author":"Hedner","year":"1988","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0140-6736(91)90729-9","article-title":"Control of haemostasis with recombinant factor VIIa in patient with inhibitor to factor VIII","volume":"338","author":"Ingerslev","year":"1991","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2516.2010.02460.x-BIB19|cit19","first-page":"S129","article-title":"Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency","volume":"9","author":"Ingerslev","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2516.2006.01421.x","article-title":"Successful concurrent triple surgery in an adolescent patient with haemophilia A and inhibitors treated with recombinant factor VIIa","volume":"13","author":"Janic","year":"2007","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2516.1999.00314.x","article-title":"Use of recombinant factor VIIa (NovoSeven) in a haemophilia A patient with inhibitor in Kuwait","volume":"5","author":"Kanyike","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1046\/j.1365-2516.2002.00649.x","article-title":"Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors","volume":"8","author":"Konkle","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000097697","article-title":"Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma anad administration of recombinant factor VIII and activated factor VII","volume":"35","author":"Koyama","year":"2006","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2516.2005.01051.x","article-title":"Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor","volume":"11","author":"Laguna","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2516.2006.01191.x","article-title":"A successful use of recombinant factor VIIa in a patient with inhibitors, for bilateral cataract operation and circumcision","volume":"12","author":"Leblebisatan","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2516.2004.00882.x","article-title":"Effective and safe use of recombinant factor VIIa (NovoSeven) in elderly mild haemophilia A patients with high-titre antibodies against factor VIII","volume":"10","author":"Leebeek","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2516.1999.t01-2-00294.x","article-title":"Postoperative use of rFVIIa by continuous infusion in a haemophilic boy","volume":"5","author":"Lorenzo","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1365-2141.2003.04173.x","article-title":"A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation","volume":"120","author":"Ludlam","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0300-2977(98)00111-9","article-title":"Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and Belgium","volume":"53","author":"Mauser-Bunschoten","year":"1998","journal-title":"Neth J Med"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2516.2002.00667.x","article-title":"Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors","volume":"8","author":"Mauser-Bunschoten","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2106\/00004623-200411000-00026","article-title":"Total knee arthroplasty using recombinant factor VII in hemophilia-A patients with inhibitors. A report of three cases","volume":"86-A","author":"Mehta","year":"2004","journal-title":"J Bone Joint Surg Am"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00001721-199804000-00012","article-title":"Management of an anti-factor VIII inhibitor occurring during surgical procedure with continuous infusion of Novoseven","volume":"9","author":"Menart","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1046\/j.1365-2516.1998.00186.x","article-title":"Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor","volume":"4","author":"Montoro","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0278-2391(03)00324-0","article-title":"Intraoral Hemostasis using a recombinant activated factor VII preparation in a hemophilia A patient with inhibitor","volume":"61","author":"Morimoto","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.0007-1048.2001.03324.x","article-title":"Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors","volume":"116","author":"O\u2019Connell","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.0007-1048.2001.03297.x","article-title":"Massive pseudotumour resection with recombinant factor VIIa (NovoSeven) cover","volume":"116","author":"O\u2019Connell","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0025-6196(12)61340-8","article-title":"Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor","volume":"69","author":"O\u2019Marcaigh","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.mbc.0000175480.85880.e2","article-title":"Short-course use of recombinant factor VIIa in a haemophilia patient with inhibitor undergoing cataract surgeries","volume":"16","author":"Pekcelen","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1365-2516.2002.00690.x","article-title":"Sequential treatment with bolus and continuous infusion of recombinant factor VIIa for hip arthroplasty in a patient with haemophilia A and inhibitor","volume":"8","author":"Perez","year":"2002","journal-title":"Haemophilia"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2516.2010.02460.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2516.2004.00938.x","article-title":"Surgery in haemophilic patients with inhibitor: 20\u2003years of experience","volume":"10","author":"Quintana-Molina","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2516.1999.00351.x","article-title":"Major surgery for a gastric cancer in a haemophilic with high inhibitor titre successfully performed by the use of recombinant FVIIa","volume":"5","author":"Rocino","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1365-2516.2003.00803.x","article-title":"Elective orthopaedic surgery for inhibitor patients","volume":"9","author":"Rodriguez-Merchan","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2516.2003.00693.x","article-title":"Efficacy of NovoSeven(R) during surgery on a haemophiliac with previous history of inhibitors","volume":"9","author":"Saba","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1055\/s-0037-1616517","article-title":"Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors","volume":"86","author":"Santagostino","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2516.1999.00319.x","article-title":"Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency","volume":"5","author":"Scharrer","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2141.1991.tb04468.x","article-title":"Prolonged recombinant activated factor VII (rFVIIa) treatment for severe bleeding in a factor-IX-deficient patient with an inhibitor","volume":"78","author":"Schmidt","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2516.2001.00483.x","article-title":"Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: Perioperative management using high- dose continuous infusion factor VIII and recombinant factor VIIa","volume":"7","author":"Sheth","year":"2001","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00001721-200412000-00009","article-title":"Intestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors: a report of five cases","volume":"15","author":"Slaoui","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1055\/s-0037-1616516","article-title":"Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10\u2003IU\u2003ml\u22121 is associated with an increased incidence of bleeding","volume":"86","author":"Smith","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1365-2141.1996.435968.x","article-title":"rVIIa therapy to secure haemostasis during central line insertion in children with high-responding FVIII inhibitors","volume":"92","author":"Smith","year":"1996","journal-title":"Br J Haematol"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2516.2010.02460.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000057296","article-title":"Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitors","volume":"32","author":"Smith","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"Suppl. 3","key":"10.1111\/j.1365-2516.2010.02460.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2516.2006.01267.x","article-title":"Total joint replacement in patients with inhibitors","volume":"12","author":"Solimeno","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2516.2000.00400.x","article-title":"Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases","volume":"6","author":"Tagariello","year":"2000","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1046\/j.1351-8216.2003.00820.x","article-title":"Concurrent total hip and knee replacements in a patient with haemophilia with inhibitors using recombinant factor VIIa by continuous infusion","volume":"9","author":"Tagariello","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2516.2004.00784.x","article-title":"Excision of pseudotumour in a patient with haemophilia A and inhibitor managed with recombinant factor VIIa","volume":"10","author":"Takedani","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0609.1998.tb01105.x","article-title":"Optimal care of inhibitor patients during surgery 271","volume":"63","author":"Vermylen","year":"1998","journal-title":"Eur J Haematol Suppl"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB57|cit57","first-page":"800a","article-title":"Orthotopic liver transplantation in a severe hemophilia A patient with factor VIII inhibitors","volume":"102","author":"Warner","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2516.2008.01952.x","article-title":"Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophiliac patients with inhibitors","volume":"15","author":"Giangrande","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2516.2009.02149.x","article-title":"Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa","volume":"16","author":"Takedani","year":"2010","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02460.x-BIB60|cit60","unstructured":"NovoSeven Prescribing Information 2008"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2010.02460.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2516.2010.02460.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T23:01:25Z","timestamp":1712185285000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2010.02460.x"}},"subtitle":["SURGICAL EXPERIENCE WITH RFVIIA IN HAEMOPHILIA"],"short-title":[],"issued":{"date-parts":[[2011,2,7]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2010.02460.x","relation":{},"ISSN":["1351-8216"],"issn-type":[{"value":"1351-8216","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,7]]}}}